Eli Lilly & Co. (LLY)
1014.49
-19.07
(-1.85%)
USD |
NYSE |
Dec 04, 16:00
1017.26
+2.77
(+0.27%)
Pre-Market: 05:38
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 907.99B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 23.15% |
| Valuation | |
| PE Ratio | 50.17 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 15.57 |
| Price to Book Value | 38.16 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.50 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 1.786 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 34.47% |
Profile
| Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN. |
| URL | http://www.lilly.com |
| Investor Relations URL | https://investor.lilly.com/ |
| HQ State/Province | Indiana |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 05, 2026 (est.) |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 14, 2025 |
Ratings
Profile
| Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN. |
| URL | http://www.lilly.com |
| Investor Relations URL | https://investor.lilly.com/ |
| HQ State/Province | Indiana |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Feb. 05, 2026 (est.) |
| Last Earnings Release | Oct. 30, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 14, 2025 |